Healthcare Services company Dr. Lal Pathlabs announced Q3FY25 results Revenue increased by 10.7% from Rs 597 crore in Q3FY25 to Rs 539 crore in Q3FY24.. EBITDA increased by 9.6% from Rs 154 crore in Q3FY25 to Rs 141 crore in Q3FY24, with a margin of 25.8%. PAT increased by 19.3% from Rs 98 crore in Q3FY25 to Rs 82 crore in Q3FY24, with a margin for of 16.4%. Third Interim Dividend of Rs. 6 per share for FY25. Result PDF